{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:24:01Z","timestamp":1787027041033,"version":"build-2736575974"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T00:00:00Z","timestamp":1678924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      In patients with limited peritoneal metastasis (PM) originating from colorectal cancer, cytoreductive surgery (CRS) followed by hyperthermic intraperitoneal chemotherapy (HIPEC) is a potentially curative treatment option. This combined treatment modality using HIPEC with mitomycin C (MMC) for 90 minutes proved to be superior to systemic chemotherapy alone, but no benefit of adding HIPEC to CRS alone was shown using oxaliplatin-based HIPEC during 30 minutes. We investigated the impact of treatment temperature and duration as relevant HIPEC parameters for these two chemotherapeutic agents in representative preclinical models. The temperature- and duration- dependent efficacy for both oxaliplatin and MMC was evaluated in an\n                      <jats:italic>in vitro<\/jats:italic>\n                      setting and in a representative animal model.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In 130 WAG\/Rij rats, PM were established through i.p. injections of rat CC-531 colon carcinoma cells with a signature similar to the dominant treatment-resistant CMS4 type human colorectal PM. Tumor growth was monitored twice per week using ultrasound, and HIPEC was applied when most tumors were 4-6\u00a0mm. A semi-open four-inflow HIPEC setup was used to circulate oxaliplatin or MMC through the peritoneum for 30, 60 or 90 minutes with inflow temperatures of 38\u00b0C or 42\u00b0C to achieve temperatures in the peritoneum of 37\u00b0C or 41\u00b0C. Tumors, healthy tissue and blood were collected directly or 48 hours after treatment to assess the platinum uptake, level of apoptosis and proliferation and to determine the healthy tissue toxicity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:italic>In vitro<\/jats:italic>\n                      results show a temperature- and duration- dependent efficacy for both oxaliplatin and MMC in both CC-531 cells and organoids. Temperature distribution throughout the peritoneum of the rats was stable with normothermic and hyperthermic average temperatures in the peritoneum ranging from 36.95-37.63\u00b0C and 40.51-41.37\u00b0C, respectively. Treatments resulted in minimal body weight decrease (&amp;lt;10%) and only 7\/130 rats did not reach the endpoint of 48 hours after treatment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Both elevated temperatures and longer treatment duration resulted in a higher platinum uptake, significantly increased apoptosis and lower proliferation in PM tumor lesions, without enhanced normal tissue toxicity. Our results demonstrated that oxaliplatin- and MMC-based HIPEC procedures are both temperature- and duration-dependent in an\n                      <jats:italic>in vivo<\/jats:italic>\n                      tumor model.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2023.1122755","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T07:22:19Z","timestamp":1679037739000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Elevated temperatures and longer durations improve the efficacy of oxaliplatin- and mitomycin C-based hyperthermic intraperitoneal chemotherapy in a confirmed rat model for peritoneal metastasis of colorectal cancer origin"],"prefix":"10.3389","volume":"13","author":[{"given":"Roxan F. C. P. A.","family":"Helderman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bella","family":"Bokan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor G. W.","family":"van Bochove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans M.","family":"Rodermond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsy","family":"Thijssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter","family":"Marchal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arezo","family":"Torang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daan R.","family":"L\u00f6ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolaas A. P.","family":"Franken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Petra","family":"Kok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter J.","family":"Tanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Crezee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlene L.","family":"Oei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,16]]},"reference":[{"key":"B1","volume-title":"Cancer, peritoneal metastasis","author":"Desai","year":"2020"},{"key":"B2","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1186\/1471-2407-10-689","article-title":"Evaluation of best supportive care and systemic chemotherapy as treatment stratified according to the retrospective peritoneal surface disease severity score (PSDSS) for peritoneal carcinomatosis of colorectal origin","volume":"10","author":"Pelz","year":"2010","journal-title":"BMC Cancer"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v9.i3.121","article-title":"Gastric peritoneal carcinomatosis - a retrospective review","volume":"9","author":"Tan","year":"2017","journal-title":"World J Gastrointest Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/medicines5010016","article-title":"Ovarian cancers: Genetic abnormalities, tumor heterogeneity and progression, clonal evolution and cancer stem cells","volume":"5","author":"Testa","year":"2018","journal-title":"Medicines (Basel)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41572-021-00326-6","article-title":"Primary and metastatic peritoneal surface malignancies","volume":"7","author":"Cortes-Guiral","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1708618","article-title":"Hyperthermic intraperitoneal chemotherapy in ovarian cancer","volume":"378","author":"van Driel","year":"2018","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.01688","article-title":"Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases (CYTO-CHIP study): A propensity score analysis","volume":"37","author":"Bonnot","year":"2019","journal-title":"J Clin Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2020.10.006","article-title":"Long term survival in patients with peritoneal metastasised gastric cancer treated with cytoreductive surgery and HIPEC: A multi-institutional cohort from PSOGI","volume":"47","author":"Brandl","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-008-9966-2","article-title":"8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer","volume":"15","author":"Verwaal","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25116","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis","volume":"116","author":"Franko","year":"2010","journal-title":"Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.19.7160","article-title":"Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin","volume":"27","author":"Elias","year":"2009","journal-title":"J Clin Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.9640","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience","volume":"27","author":"Yan","year":"2009","journal-title":"J Clin Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2016.03.017","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1000 patients with perforated appendiceal epithelial tumours","volume":"42","author":"Ansari","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3840","DOI":"10.18632\/oncotarget.26972","article-title":"Multidisciplinary palliation for unresectable recurrent rectal cancer: hypoxic pelvic perfusion with mitomycin c and oxaliplatin in patients progressing after systemic chemotherapy and radiotherapy, a retrospective cohort study","volume":"10","author":"Guadagni","year":"2019","journal-title":"Oncotarget"},{"key":"B15","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3390\/cancers11010078","article-title":"Variation in clinical application of hyperthermic intraperitoneal chemotherapy: A review","volume":"11","author":"Helderman","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"567","DOI":"10.3390\/jcm7120567","article-title":"Systematic review of variations in hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal metastasis from colorectal cancer","volume":"7","author":"Yurttas","year":"2018","journal-title":"J Clin Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(19)30239-0","article-title":"Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial","volume":"4","author":"Klaver","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30322-3","article-title":"Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-PRODIGE 15): a randomised, phase 3 study","volume":"21","author":"Goere","year":"2020","journal-title":"Lancet Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30599-4","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Qu\u00e9net","year":"2021","journal-title":"Lancet Oncol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.3390\/cancers13143430","article-title":"Preclinical In vivo-models to investigate HIPEC; current methodologies and challenges","volume":"13","author":"Helderman","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.3390\/cells9081775","article-title":"The temperature-dependent effectiveness of platinum-based drugs mitomycin-c and 5-FU during hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer cell lines","volume":"9","author":"Helderman","year":"2020","journal-title":"Cells"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1080\/02656730210123534","article-title":"Thermal enhancement of melphalan and oxaliplatin cytotoxicity in vitro","volume":"18","author":"Urano","year":"2002","journal-title":"Int J Hyperthermia"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.11206","article-title":"Organoids from colorectal peritoneal metastases as a platform for improving hyperthermic intraperitoneal chemotherapy","volume":"106","author":"Ubink","year":"2019","journal-title":"Br J Surg"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/jso.24906","article-title":"5-fluorouracil combined with cisplatin and mitomycin c as an optimized regimen for hyperthermic intraperitoneal chemotherapy in gastric cancer","volume":"117","author":"Murata","year":"2018","journal-title":"J Surg Oncol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.3390\/biomedicines10071610","article-title":"Non-invasive imaging and scoring of peritoneal metastases in small preclinical animal models using ultrasound: A preliminary trial","volume":"10","author":"Helderman","year":"2022","journal-title":"Biomedicines"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2006.339","article-title":"Clonogenic assay of cells in vitro","volume":"1","author":"Franken","year":"2006","journal-title":"Nat Protoc"},{"key":"B27","volume-title":"FASTQC. a quality control tool for high throughput sequence data","author":"Andrews","year":"2010"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btw354","article-title":"MultiQC: summarize analysis results for multiple tools and samples in a single report","volume":"32","author":"Ewels","year":"2016","journal-title":"Bioinformatics"},{"key":"B29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.14806\/ej.17.1.200","article-title":"Cutadapt removes adapter sequences from high-throughput sequencing reads","volume":"17","author":"Martin","year":"2011","journal-title":"EMBnet.journal"},{"key":"B30","first-page":"2","article-title":"preprocessCore: A collection of pre-processing functions","volume-title":"R package version","author":"Bolstad","year":"2013"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bts034","article-title":"The sva package for removing batch effects and other unwanted variation in high-throughput experiments","volume":"28","author":"Leek","year":"2012","journal-title":"Bioinformatics"},{"key":"B32","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41389-020-00250-6","article-title":"Exploring and modelling colon cancer inter-tumour heterogeneity: opportunities and challenges","volume":"9","author":"Buikhuisen","year":"2020","journal-title":"Oncogenesis"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-017-0011-5","article-title":"Consensus molecular subtypes of colorectal cancer are recapitulated in in vitro and in vivo models","volume":"25","author":"Linnekamp","year":"2018","journal-title":"Cell Death Differ"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"3516","DOI":"10.3390\/cancers12123516","article-title":"A four-inflow construction to ensure thermal stability and uniformity during hyperthermic intraperitoneal chemotherapy (HIPEC) in rats","volume":"12","author":"Loke","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.26667","article-title":"Body surface area-based versus concentration-based intraperitoneal perioperative chemotherapy in a rat model of colorectal peritoneal surface malignancy: pharmacologic guidance towards standardization","volume":"10","author":"Lemoine","year":"2019","journal-title":"Oncotarget"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.10788","article-title":"Histopathological and molecular classification of colorectal cancer and corresponding peritoneal metastases","volume":"105","author":"Ubink","year":"2018","journal-title":"Br J Surg"},{"key":"B38","doi-asserted-by":"publisher","first-page":"666","DOI":"10.17235\/reed.2020.6755\/2019","article-title":"Prophylactic HIPEC with oxaliplatin might be of benefit in T4 and perforated colon cancer: another possible interpretation of the COLOPEC results","volume":"112","author":"Segura-Sampedro","year":"2020","journal-title":"Rev Esp Enferm Dig"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30693-8","article-title":"HIPEC for colorectal peritoneal metastases","volume":"22","author":"Klempner","year":"2021","journal-title":"Lancet Oncol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2018.10.542","article-title":"HIPEC with oxaliplatin for colorectal peritoneal metastasis: The end of the road","volume":"45","author":"Ceelen","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12885-018-4096-0","article-title":"HIPECT4: multicentre, randomized clinical trial to evaluate safety and efficacy of hyperthermic intra-peritoneal chemotherapy (HIPEC) with mitomycin c used during surgery for treatment of locally advanced colorectal carcinoma","volume":"18","author":"Arjona-S\u00e1nchez","year":"2018","journal-title":"BMC Cancer"},{"key":"B42","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1080\/02656736.2020.1852324","article-title":"Demonstration of treatment planning software for hyperthermic intraperitoneal chemotherapy in a rat model","volume":"38","author":"L\u00f6ke","year":"2021","journal-title":"Int J Hyperthermia"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2020.1862364","article-title":"Simulating drug penetration during hyperthermic intraperitoneal chemotherapy","volume":"28","author":"Loke","year":"2021","journal-title":"Drug Deliv"},{"key":"B44","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.addr.2020.01.003","article-title":"Molecular and biological rationale of hyperthermia as radio- and chemosensitizer","author":"Oei","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"key":"B45","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s13014-015-0462-0","article-title":"Effects of hyperthermia on DNA repair pathways: one treatment to inhibit them all","volume":"10","author":"Oei","year":"2015","journal-title":"Radiat Oncol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.dnarep.2014.02.007","article-title":"Alternative end-joining pathway(s): Bricolage at DNA breaks","volume":"17","author":"Frit","year":"2014","journal-title":"DNA Repair"},{"key":"B47","article-title":"Thermodynamic profiling during irreversible electroporation in porcine liver and pancreas: a case study series","volume":"5","author":"Agnass","year":"2020","journal-title":"J Clin Transl Res"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3109\/02656736.2016.1157216","article-title":"Improving efficacy of hyperthermia in oncology by exploiting biological mechanisms","volume":"32","author":"van den Tempel","year":"2016","journal-title":"Int J Hyperthermia"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.3390\/cancers14051158","article-title":"Prolonged exposure to oxaliplatin during HIPEC improves effectiveness in a preclinical micrometastasis model","volume":"14","author":"Seyfried","year":"2022","journal-title":"Cancers"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.17861","article-title":"The effect of thermal dose on hyperthermia-mediated inhibition of DNA repair through homologous recombination","volume":"8","author":"van den Tempel","year":"2017","journal-title":"Oncotarget"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1172\/JCI44952","article-title":"IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cells","volume":"121","author":"Fisher","year":"2011","journal-title":"J Clin Invest"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3109\/02656736.2012.677933","article-title":"Old and new facts about hyperthermia-induced modulations of the immune system","volume":"28","author":"Frey","year":"2012","journal-title":"Int J Hyperthermia"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3109\/02656730903413375","article-title":"Tumour infiltrating host cells and their significance for hyperthermia","volume":"26","author":"Muthana","year":"2010","journal-title":"Int J Hyperthermia"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1379\/1466-1268(1996)001<0167:CSEOHS>2.3.CO;2","article-title":"Cell surface expression of heat shock proteins and the immune response","volume":"1","author":"Multhoff","year":"1996","journal-title":"Cell Stress Chaperones"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1122755\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T07:22:29Z","timestamp":1679037749000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1122755\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,16]]},"references-count":54,"alternative-id":["10.3389\/fonc.2023.1122755"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2023.1122755","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,16]]},"article-number":"1122755"}}